Takeda and TiGenix secure EU approval for stem cell therapyZenopaTakeda and TiGenix have had their allogeneic stem cell therapy Alofisel approved for use by the EU, the first of its kind to be licensed in the 28-nation bloc. Previously known as Cx601, … Continue reading
Targeted OncologyExpert Discusses Immunotherapy Growth in Treatment Landscape of NSCLCTargeted OncologyPecot: We have several different types of combinations. Ones that I discussed were chemotherapy plus immunotherapy, and some of those trials looked g… Continue reading
Medical Xpress |
A combination of cancer immunotherapies could save more lives
Medical Xpress Dr Catherine Pickworth, from Cancer Research UK, said: “Immunotherapy treatments are already showing huge promise for a number of cancer types, but they don’t work for everyone. This work in mice suggests that using two types of immunotherapy could be … |